NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has received FDA approval to move forward with its Virtue Trial ...

The drug-eluting stent market is anticipated to grow at a CAGR of 8.20% from US$11.499 billion in 2025 to US$17.049 billion ...

It is quite clear that the Gujarat government’s rather ill-informed decision will penalise Indian manufacturers who today hold over 73% of the domestic market and export over 5 lakh stents annually to ...

The global market for Peripheral Artery Disease (PAD) treatments has been witnessing significant growth, with the market size valued at $3,524.77 million in 2019. It is projected to escalate to $5,715 ...

Report Ocean has published a new report on the Saudi Arabia Implantable Drug Delivery Devices market, delivering an extensive analysis of key factors such as market restraints, dr ...

Y. Vijayachandra Reddy, senior consultant interventional cardiologist at Apollo Hospitals, Chennai, discusses personalized ...

Discover how IVBT impacts long-term outcomes in complex in-stent restenosis—read the full report for key clinical insights.

Boston Scientific today shared study data supporting the use of its Eluvia drug-eluting stent for treating PAD.

The global peripheral vascular devices market, valued at USD 4.7 billion in 2022, is projected to expand at a robust CAGR of 6.6%, reaching USD 8.9 billion by 2032, according to Future Market Insights ...

R3 Vascular announced that a doctor treated the first patient in the ELITE-BTK pivotal trial of its drug-eluting ...

R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce ...

MANILA, Philippines — Bus companies face the cancellation or suspension of their public transportation franchises after some of their drivers and conductors tested positive for illegal drug use.